
GC14129
Nilotinib
Also listed as Nilotinib(AMN-107)
Nilotinib(AMN-107) is a selective oral tyrosine kinase inhibitor that inhibits the autophosphorylation of native Bcr-Abl (WT p210) and mutant Bcr-Abl (E281K, E292K, F317L, M351T, and F486S) with IC50 values of 20, 42, 31, 38, 29, and 41nM, respectively
ChemicalCAS641571-10-0MW529.53FormulaC28H22F3N7O
- CAS number
- 641571-10-0
- Molecular weight
- 529.53
- Formula
- C28H22F3N7O
- Solubility
- ≥ 26·5mg/mL in DMSO, ≥ 5mg/mL in EtOH with ultrasonic and warming
- InChIKey
- HHZIURLSWUIHRB-UHFFFAOYSA-N
- Catalogue number
- GC14129
- Brand
- GLPBIO
Computed properties PubChem CID 644241 · XLogP 4.9 · TPSA 97.6 Ų · H-bond donors 2
- XLogP
- 4.9
- TPSA
- 97.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 9
- Rotatable bonds
- 6
- Heavy atoms
- 39
SMILES CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
Computed descriptors from PubChem (CID 644241), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il